Madison Wis. Mithridion the University of Wisconsin-Madison spinoff developing a drug for people with Alzheimer's disease has closed its first round of financing with $1.6 million of which it has received the first portion that will go toward buying lab equipment hiring scientists and developing drug candidates. Trevor Twose Mithridion's